Does the use of cholinesterase inhibitors increase the risk of receiving an anticholinergic drug for urinary incontinence in patients with dementia?
Cholinesterase inhibitors may cause urinary incontinence, leading to a potentially harmful prescribing cascade of anticholinergic drugs in patients with dementia.
Use of cholinesterase inhibitors is associated with an increased risk of receiving an anticholinergic drug to manage urinary incontinence. The use of an anticholinergic drug in this setting may represent a clinically important prescribing cascade. Clinicians should consider the possible contributing role of cholinesterase inhibitors in new-onset or worsening urinary incontinence and the potential risk of coprescribing cholinesterase inhibitors and anticholinergic drugs to patients with dementia.
Gill et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: